Opendata, web and dolomites
H2020 projects about "malignant"
The page lists 117 projects related to the topic "malignant".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | LuMaSense | A Non-Invasive Test for Guiding Follow–up of Patients with CT-Detected Lung Nodules | 2015 |
| 3 | ApoptoMDS | Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? | 2015 |
| 4 | CRCStemCellDynamics | Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers | 2015 |
| 5 | MEL-PLEX | Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine | 2014 |
| 6 | SAGE-CARE | SemAntically integrating Genomics with Electronic health records for Cancer CARE | 2014 |
| 7 | AEGLE | AEGLE (Ancient Greek: Αá¼´γλη) – An analytics framework for integrated and personalized healthcare services in Europe | 2015 |
| 8 | GLYCANC | Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer | 2015 |
| 9 | VIBRA | Very fast Imaging by Broadband coherent RAman | 2015 |
| 10 | CONSORT | Controlled Singlet Oxygen Release Photosensitizers in Photodynamic Therapy | 2015 |
| 11 | SmartMammaCAD | Intelligent Automated System for detecting Diagnostically Challenging Breast Cancers | 2015 |
| 12 | SCARtool | Scattered radiation reduction tool to improve computer-aided diagnosis performance in digital breast tomosynthesis | 2015 |
| 13 | MatrixMacrophages | Matrix degrading macrophages in cancer growth and invasion | 2015 |
| 14 | S-OS | Exosomes as microenvironmental cue for engaging mesenchymal stem cells in osteosarcoma progression | 2016 |
| 15 | LYMPHOSIGN | Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma | 2015 |
| 16 | Enhancer ID | Identification and functional characterization of mammalian enhancers and transcriptional co-factors during cellular signaling and cell fate transitions | 2015 |
| 17 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 18 | COMBIOSCOPY | Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy | 2015 |
| 19 | PIPPI | Protein-excipient Interactions and Protein-Protein Interactions in formulation | 2016 |
| 20 | ULTIMA | ULTrafast Imaging sensor for Medical Applications | 2015 |
| 21 | ARVisS | Augmented Reality Vision for Surgery | 2015 |
| 22 | ThyroTrust | A novel reliable diagnostic device to avoid unnecessary thyroid surgery | 2016 |
| 23 | H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma | 2016 |
| 24 | Bcl-Inhib | Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer | 2015 |
| 25 | Gene2Skin | Gene2Skin - Roadmap for advanced genetic engineering-based skin therapies | 2015 |
| 26 | RELYUBL | Regulation of lymphocyte biology by ubiquitin and ubiquitin like modifiers | 2016 |
| 27 | TROJANANOHORSE | Hybrid immune-eluding nanocrystals as smart and active theranostic weapons against cancer | 2016 |
| 28 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 29 | channelopathies | Type 1 reyanodine receptor Structure and regulation by post-translational modifications and small molecules. | 2016 |
| 30 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 31 | MCNTMTDC | Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours | 2017 |
| 32 | DynOMIS | Dynamic Origins of MHC class I Selector function | 2016 |
| 33 | MPSC | Membrane Potential and Stem Cell Potency in Normal and Malignant Tissues | 2016 |
| 34 | PERICYTEStroma | Pericyte-derived tumor stroma – a target for cancer therapy | 2016 |
| 35 | NVHSC | Neurovascular interplay in the hematopoietic stem cell niches in homeostasis and myeloproliferative neoplasias | 2016 |
| 36 | MESO-JBIR-102 | Development of the aza-Prins reaction; synthesis and biological evaluation of JBIR-102 | 2016 |
| 37 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 38 | MitoVin | Mechanism and Consequences of the Interplay between Mitosis and Human Papillomavirus Initial Infection | 2016 |
| 39 | Autonomous CLL-BCRs | Role of autonomous B cell receptor signalling and external antigen in the pathogenesis of chronic lymphocytic leukaemia (CLL) | 2016 |
| 40 | MYELOMANEXT | Integrated next-generation flow cytometry and sequencing to uncover the pathway of curability in multiple myeloma | 2016 |
| 41 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 42 | CONQUEST | CONQUEST: Enabling advanced medical imaging | 2016 |
| 43 | PAMMOTH | Photoacoustic/Ultrasound Mammoscopy for evaluating screening-detected abnormalities in the breast | 2017 |
| 44 | DiVineGenoMe | Decoding cell-to-cell variation in genome integrity maintenance | 2017 |
| 45 | CUPIDO | Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts | 2017 |
| 46 | GlycoImaging | Imaging and detection of tumor-associated glycan structures on tumor cells | 2017 |
| 47 | Bio-ICD | Biological auto-detection and termination of heart rhythm disturbances | 2017 |
| 48 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 49 | LEUKEMIC-TEs | Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia | 2017 |
| 50 | PHYSBIOHSC | Understanding the physical biology of adult blood stem cells | 2017 |
| 51 | SCALTIE | Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy | 2017 |
| 52 | GlimS | Patient-specific tumour growth model for quantification of mechanical 'markers' in malignant gliomas: Implications for treatment outcomes. | 2017 |
| 53 | APACHE | Atmospheric Pressure plAsma meets biomaterials for bone Cancer HEaling | 2017 |
| 54 | SIOMICS | SIngle-cell multi-OMICs approach to study intra-tumour heterogeneity of soft tissue Sarcomas | 2017 |
| 55 | IMMUNO-RQC | Role of Listerin ubiquitin ligase in MHC-I antigen presentation | 2017 |
| 56 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 57 | OR-HMC | Assay for cancer diagnostics by quantification of 5hmC | 2017 |
| 58 | Ovage | OvAge: an innovative, user-friendly digital methodology that quantifies ovarian reserve by integratingclinical, biochemical and 3D-sonographic data to help decision-making in all phases of woman life | 2017 |
| 59 | CuHypMECH | New Nuclear Medicine Imaging Radiotracer 64Cu(II) for diagnosing Hypoxia Conditions Based on the Cellular Copper Cycle | 2017 |
| 60 | StroMaP | Stromal stress networks underlying phenotypic plasticity and tumor fitness | 2017 |
| 61 | deFIBER | Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment | 2018 |
| 62 | MICRONEX | Microbioreactor platforms as in vivo-like systems to probe the role of Neuroblastoma-derived Exosomes in cancer dissemination | 2017 |
| 63 | JetCell | Microfluidic bubble JET flow CELL sorter for cell therapy | 2018 |
| 64 | ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow | 2018 |
| 65 | GlycoEdit | New Chemical Tools for Precision Glycotherapy | 2017 |
| 66 | SOFT | SOFT, the first camera-based colorectal cancer screening test to detect occult blood in faeces immediately and with no lab analysis. | 2017 |
| 67 | MEL-Interactions | An integrative approach for the exploration of melanoma genetic and immunological interactions | 2018 |
| 68 | EDROMA | Novel nanomedicine for the treatment of glioma | 2018 |
| 69 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 70 | RAMAN-Dx | Raman spectroscopy for early diagnosis of oral pre-cancer and cancer using minimally invasive samples | 2018 |
| 71 | MaGMa | Applying Metabolomics to Unveil follow-up treatment biomarkers and Identify Novel TherapeuticTargets in Glioblastoma | 2018 |
| 72 | GENESIS | GENetics and the Electrocardiogram for predicting Scd rISk | 2019 |
| 73 | IGpath | Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas | 2018 |
| 74 | MECHANOSITY | Mechanical regulation of cellular behaviour in 3D viscoelastic materials | 2019 |
| 75 | KILNEV | Killing Senescent Cells as a Novel Method to Eliminate Nevi | 2018 |
| 76 | HiMIN | Histone H3.3 oncogenic mutations: a role in genome instability through altered DNA repair and replication fork stability? | 2018 |
| 77 | SKin SCiENCE | Skin Keratinocyte Stem CEll proliferatioN in field CancErisation | 2018 |
| 78 | TRANSREG | Dissecting the role of Translational Regulation in Tumorigenesis | 2018 |
| 79 | mitozippers | Mitochondrial membrane-targeted compounds for cancer therapy | 2018 |
| 80 | GLIOGUIDE | Commercialising a novel glioblastoma targeted therapy and a companion diagnostic compound | 2018 |
| 81 | EditMHC | How MHC-I editing complexes shape the hierarchical immune response | 2019 |
| 82 | EpiGlioT | Epigenetic Glioblastoma Therapeutics | 2018 |
| 83 | KERMA | A NEW VERIFICATION SYSTEM FOR COMPLEX RADIOTHERAPY TREATMENTS | 2018 |
| 84 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 85 | OXIGENATED | Hemoglobin based Protein Nanocarriers for Tumour Oxygenation and a more effective Photodynamic Therapy | 2019 |
| 86 | BERMES | A Novel BERberine derivative for Malignant MESothelioma | 2018 |
| 87 | SCIPER | Studying Cancer Individuality by Personal and Predictive Drug Screening and Differential OMICs | 2018 |
| 88 | CANCER INVASION | Deciphering and targeting the invasive nature of Diffuse Intrinsic Pontine Glioma | 2019 |
| 89 | PRIMAGE | PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers | 2018 |
| 90 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 91 | LeukemiaEnviron | SIGNALING PROPENSITY IN THE MICROENVIRONMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA | 2019 |
| 92 | PRinTERs | Post-transcriptional regulation of effector function in T cells by RNA binding proteins | 2019 |
| 93 | ImmuNiche | Identifying spatial determinants of immune cell fate commitment | 2019 |
| 94 | IntratumoralNiche | Defining heterocellular signalling within the intratumoral stem cell niche of colorectal cancer | 2019 |
| 95 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 96 | PreNeolithicMalaria | Evolutionary history of the sickle cell trait among Central African hunter-gatherers and farmers | 2019 |
| 97 | GLIOHAB | Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation | 2019 |
| 98 | EVOMET | The rise and fall of metastatic clones under immune attack | 2019 |
| 99 | THERAPROBES | Biodegradable fluorescent nanoprobes for early detection of (pre)malignant lesions of the gastrointestinal tract | 2019 |
| 100 | BispecificsThatClick | Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators | 2019 |
| 101 | INFORM | Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs | 2020 |
| 102 | SingCelCD | Single Cell approaches for the study of oncogenic processes during coeliac disease. | 2019 |
| 103 | RegulatioNFkB | Deciphering transcriptional regulation of NF-kB target genes using integrative omics approaches | 2019 |
| 104 | MultiPan | A Multi-omics Approach To Decode Epigenetic Lesions In Pancreatic Cancer Development | 2019 |
| 105 | Hyalcis | Hyaluronic-Cisplatin Film for Implant in Malignant Mesothelioma Recurrence | 2019 |
| 106 | T-NHL SUPRESSORS | Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma | 2019 |
| 107 | INJURMET | Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasis | 2019 |
| 108 | SCMS | ScreenCancer Mole Scanner - Easily accessible mole scanning service for early detection of skin cancer. | 2019 |
| 109 | Miiskin | ML-powered app and platform to identify skin changes over time | 2019 |
| 110 | NUCDDR | Nucleolar Responses to DNA Damage: rDNA, an emerging hub of genome instability | 2020 |
| 111 | METABOLIGHT | Optical imaging platform to unravel metabolic reprogramming of cancer: a path for improved treatments | 2020 |
| 112 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |
| 113 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 114 | ChRONAM-H | Chromatin Regulation Of Normal And Malignant Haematopoiesis | 2020 |
| 115 | OPEN P-CAN | Dissecting the role of mitochondrial dynamics in pancreatic carcinogenesis | 2020 |
| 116 | MRTFSen | MRTF/SRF signalling in regulation of cell senescence and melanoma progression | 2020 |
| 117 | Catenin-Condensation | The effect of β-catenin condensation on the Wnt-pathway | 2020 |